NCT06707857 Effects of TNT on Pain, ROM and Disability in Patients With RC Tendinopathy
| NCT ID | NCT06707857 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Rotator Cuff Tendinopathy |
| Study Type | INTERVENTIONAL |
| Enrollment | 38 participants |
| Start Date | 2024-04-15 |
| Primary Completion | 2024-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 38 participants in total. It began in 2024-04-15 with a primary completion date of 2024-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
EFFECTS OF TENDON NEUROPLASTIC TRAINING ON PAIN, RANGE OF MOTION AND DISABILITY IN PATIENTS WITH ROTATOR CUFF TENDINOPATHY
Eligibility Criteria
Inclusion Criteria: * Have a current shoulder complaint lasting at least three months prior to the time of enrollment * Pain is located in the proximal lateral aspect of the upper arm (C5 dermatome) * Positive Hawkins-Kennedy test Exclusion Criteria: * Bilateral shoulder pain * Less than 90 degrees of active elevation of the arm * Corticosteroid injection within the last six weeks * Radiologically verified fracture * Glenohumeral osteoarthritis * Surgery or dislocation of the affected shoulder * Symptomatic arthritis in the Ac joint * Frozen shoulder * Symptoms derived from the cervical spine
Contact & Investigator
Saba Rafique, MS-OMPT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06707857 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Rotator Cuff Tendinopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06707857 currently recruiting?
Yes, NCT06707857 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT06707857 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT06707857 clinical trial?
NCT06707857 is sponsored by Riphah International University. The principal investigator is Saba Rafique, MS-OMPT at Riphah International University. The trial plans to enroll 38 participants.